opioid-use-disorder

Documents about opioid-use-disorder

• A Study to Evaluate the Abuse Potential of Oxymorphone Compared to Other Mu Opioid Agonists.#865422ClinicalTrials.gov
• Feasibility of Deep Brain Stimulation as a Novel Treatment for Refractory Opioid Use Disorder#905563ClinicalTrials.gov
• The remaining role and feasibility of detoxification in opioid addiction after 30 years of medication for opioid use disorder#670147HAL (France)
• A Trial of Directly Observed and Long-term Varenicline#827560ClinicalTrials.gov
• U.S. adults with opioid use disorder living with children: Treatment use and barriers to care.#371651NCBI PubMed Central
• MySafeRx™: An Integrated Mobile Platform for Buprenorphine Adherence#800600ClinicalTrials.gov
• Genetic variation in BDNF is associated with opioid use disorder severity.#1039824NCBI PubMed Central
• Understanding the characteristics and comorbidities of primary care patients with risky opioid use: Baseline data from the multi-site "Subthreshold Opioid Use Disorder Prevention" (STOP) Trial.#630937NCBI PubMed Central
• Mu-opioid and nociceptin receptors show divergent, cell-type-specific actions in the mesocorticolimbic reward system in opioid use disorder#153637HAL (France)
• Investigation of the Relationship Between Different Assesments in Individuals in Opioid Maintenance Treatment Process#802965ClinicalTrials.gov
• Integrating Treatment for Mental Disorders in Methadone Clinics in Ukraine#891629ClinicalTrials.gov
• Neurobehavioral Measurement of Substance Users in Outpatient Treatment Setting#803599ClinicalTrials.gov
• A Project to Test the Efficacy and Safety of An Innovative Treatment for Opiate Use Disorders.#850787ClinicalTrials.gov
• Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders ("EXPO" Pilot Trial)#1047886ClinicalTrials.gov
• Increasing Patient Knowledge of the Signs of Opioid Overdose and Naloxone in a Suburban Treatment Program#853434ClinicalTrials.gov
• Pharmacological and behavioral pain treatment strategies for patients with opioid use disorder.#247532NCBI PubMed Central
• Depression in Opioid Use Disorder: A Tripartite Psychopathological Model for Dual Disorders.#409126NCBI PubMed Central
• Study of the BIOPIN 6 Naltrexone Implant in Healthy Adults#826390ClinicalTrials.gov
• Integrating MOUD in Nonmedical Community Settings (Better Together)#854603ClinicalTrials.gov
• The Association Between Receiving Medications for Opioid Use Disorder and Human Immunodeficiency Virus Testing: Findings From the Rural Opioid Initiative.#157132NCBI PubMed Central
• Naloxone Treatment in Skåne County - Effect on Drug-related Mortality and Overdose-related Complications#910320ClinicalTrials.gov
• Combining Neuro-Imaging and Non-Invasive Brain Stimulation for Clinical Intervention in Opioid Use Disorder#981333ClinicalTrials.gov
• The Wrong Framework: How Opioid Restriction Policy Fails the Patients It Was Never Designed to Protect#120239OSF
• Collaborating to Heal Addiction and Mental Health in Primary Care#840039ClinicalTrials.gov
• Safety and PK Study of BICX104 With or Without Bupropion Compared to Vivitrol#866023ClinicalTrials.gov
• Incident Benzodiazepine Initiation Following Buprenorphine Treatment for Opioid Use Disorder: A Retrospective Cohort Study#313446Scholar Commons
• Adiposity and inflammation mediate altered metabolic profile in individuals with opioid use disorder.#446264NCBI PubMed Central
• Evaluation of Doxazosin to Alter the Abuse of Oxycodone#801527ClinicalTrials.gov
• Adaptive Decision Support for Addiction Treatment (ADAPT) Factorial Trial#825265ClinicalTrials.gov
• Assessment of Methadone and Buprenorphine in Interstitial Fluid#841558ClinicalTrials.gov
• 42 U.S.C. § 1395cc-6 — Opioid use disorder treatment demonstration program#594067US Code (LII)
• Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder#832149ClinicalTrials.gov
• Increasing Linkage to Family Planning Care for Individuals With Substance Use Disorder#903676ClinicalTrials.gov
• PRoducing Outcome Measures for OTP Quality Improvement#876792ClinicalTrials.gov
• Testing a Group Counseling Program for People Who Support Patients with Opioid Use Disorder – The eINSPIRE Study#2268NCBI Bookshelf
• Cost-Effectiveness of the START Hospital Addiction Consultation Service for Opioid Use Disorder Treatment.#165756NCBI PubMed Central
• Predictors of Medicaid managed care plan performance on opioid use disorder treatment quality metrics.#251213NCBI PubMed Central
• Opioid dose, duration, and risk of use disorder in Medicaid patients with musculoskeletal pain.#308981NCBI PubMed Central
• Global perspectives on telemedicine-enabled medications for opioid use disorder: Practices, priorities, and barriers.#418499NCBI PubMed Central
• RETRACE: Resilience-Guided Trait-Conditioned Craving Estimation from Wearable Physiology in Opioid Use Disorder#628287arXiv (OAI Expanded)
• RETRACE: Resilience-Guided Trait-Conditioned Craving Estimation from Wearable Physiology in Opioid Use Disorder#630149arXiv (All)
• Personalized Addiction Treatment enHancement#855123ClinicalTrials.gov
• Integrating Addiction Treatment and HIV Services Into Primary Care Clinics in Ukraine#870170ClinicalTrials.gov
• A Rubric-Guided Large Language Model Solution for Opioid Use Disorder Computable Phenotyping#972733arXiv (All)
• Investigating hierarchical control among functional networks disrupted by opioid use disorder using effective connectivity.#1053939NCBI PubMed Central
• PrEP and MOUD Rapid Access for Persons Who Inject Drugs: The CHORUS+ Study#980891ClinicalTrials.gov
• Differential Changes in Use of Medications for Opioid Use Disorder by Race-Ethnicity: Effects of a Hub-and-Spoke Model.#312591NCBI PubMed Central
• Virtual Intelligence for Transformative Lifestyle Solutions in Pain#853873ClinicalTrials.gov
• Evaluation of a Motion-Activated Refusal-Skills Training Video Game for Prevention of Substance Use Disorder Relapse#860306ClinicalTrials.gov
• Effect of Heroin Use on Immune Activation and Cardiovascular Risk in HIV#967780ClinicalTrials.gov